Update on HER2 testing for breast and upper gastrointestinal tract cancers
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Update on HER2 testing for breast and upper gastrointestinal tract cancers
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 5, Issue 3, Pages 307-318
Publisher
Future Medicine Ltd
Online
2011-06-10
DOI
10.2217/bmm.11.31
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastric Cancer: A Primer on the Epidemiology and Biology of the Disease and an Overview of the Medical Management of Advanced Disease
- (2017) Manish A. Shah et al. Journal of the National Comprehensive Cancer Network
- The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations
- (2011) Michal R. Schweiger et al. CANCER AND METASTASIS REVIEWS
- HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH)
- (2011) James E. Boers et al. HISTOPATHOLOGY
- HER2 Testing in Gastric Cancer
- (2010) Luca Albarello et al. ADVANCES IN ANATOMIC PATHOLOGY
- Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
- (2010) Masakazu Toi et al. BMC CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Advanced gastric cancer – Slow but steady progress
- (2010) Derek G. Power et al. CANCER TREATMENT REVIEWS
- Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
- (2010) F. De Vita et al. CANCER TREATMENT REVIEWS
- DNA amplifications in breast cancer: genotypic–phenotypic correlations
- (2010) Kai-Keen Shiu et al. Future Oncology
- Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies
- (2010) Shinichi Hasegawa et al. Gastric Cancer
- Genetic and Epigenetic Alteration in Gastric Carcinogenesis
- (2010) Carlos Resende et al. HELICOBACTER
- Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
- (2010) Frederick L. Baehner et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in 2010: Does Chromosome 17 Centromere Copy Number Make Any Difference?
- (2010) Jeffrey S. Ross JOURNAL OF CLINICAL ONCOLOGY
- HER2and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
- (2010) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- A study of HER2 gene amplification and protein expression in gastric cancer
- (2010) B. Yan et al. JOURNAL OF CLINICAL PATHOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Molecular Biomarker Analyses Using Circulating Tumor Cells
- (2010) Elizabeth A. Punnoose et al. PLoS One
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- (2010) Josef Rüschoff et al. VIRCHOWS ARCHIV
- Emerging Technologies for Assessing HER2 Amplification
- (2009) Frédérique Penault-Llorca et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
- (2009) J D Barros-Silva et al. BRITISH JOURNAL OF CANCER
- Bright-field In Situ Hybridization for HER2 Gene Amplification in Breast Cancer Using Tissue Microarrays
- (2009) Glenn D. Francis et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Quantitative PCR and HER2 Testing in Breast Cancer
- (2008) Massimo Barberis et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
- (2008) Julie E. Lang et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
- (2008) Mitra Tewes et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer
- (2008) M. Ignatiadis et al. CLINICAL CANCER RESEARCH
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- Review: Biological relevance of disseminated tumor cells in cancer patients
- (2008) Sabine Riethdorf et al. INTERNATIONAL JOURNAL OF CANCER
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
- (2008) J. S. Ross et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More